Skip to main content

Studienportal Gynäkologie

Weisser-Hintergrund-Logo Studienportal Gyn
Menu
  • Breast Cancer
  • Ovarian Cancer
  • Endometrium Cancer
  • Zervix Cancer
  • Gyn-Sarkome
  • English
    • Deutsch
    • العربية
    • Türkçe

Imprint

Imprint

Concept and Direction:
Prof. Dr. med. h.c. Dr. Jalid Sehouli
Susanne Fechner

Editing and Coordination:
AVISOmed medizin+media

Web Design:
Christian Suhr

Contact:
AVISOmed medizin+media
Friedelstr. 56
12047 Berlin
+49 30 400 54 244
lisa.sintermann@avisomed.de
www.avisomed.de

Person responsible for content (pursuant to § 55(2) RStV):
Susanne Fechner

An initiative of the Gynecologic Oncology Forum in cooperation with the German Ovarian Cancer Foundation, NOGGO e.V., and the AGO Study Group.

News from science and practice

New Findings from ASCO 2026

Preliminary Results of the NAPISTAR 1-01 Study

Positive results from the DUO-O study!

Highlights from ESGO 2026 and a new approval!

New final data: Immunotherapy with atezolizumab brings no additional benefit in recurrent ovarian cancer

iuvando und Studienportal Gyn kooperieren

ENGAGe AWARD STUDY GYN

Vision for ESGO 2026-2028

© Studienportal Gyn Imprint | Privacy | Contact

E-mail: info@avisomed.de

  • English
  • Deutsch (German)
  • العربية (Arabic)
  • Türkçe (Turkish)